These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3533180)

  • 21. Endocrine function after bone marrow transplantation without the use of preparative total body irradiation.
    Urban C; Schwingshandl J; Slavc I; Gamillscheg A; Hauer C; Schmid G; Kaulfersch W; Borkenstein M
    Bone Marrow Transplant; 1988 Jul; 3(4):291-6. PubMed ID: 3048494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone-marrow transplantation for haematological malignancy in childhood.
    Vowels MR; Lam-Po-Tang PR; Ford D; Mameghan H; O'Gorman-Hughes DW; Ziegler JB; Kwan YL; White L
    Med J Aust; 1986 Mar; 144(7):347-50. PubMed ID: 3007953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function.
    Leiper AD; Stanhope R; Lau T; Grant DB; Blacklock H; Chessells JM; Plowman PN
    Br J Haematol; 1987 Dec; 67(4):419-26. PubMed ID: 3322361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation.
    Wingard JR; Plotnick LP; Freemer CS; Zahurak M; Piantadosi S; Miller DF; Vriesendorp HM; Yeager AM; Santos GW
    Blood; 1992 Feb; 79(4):1068-73. PubMed ID: 1737091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height and hormonal function after bone marrow transplantation in children.
    Clement-De Boers A; Oostdijk W; Van Weel-Sipman MH; Van den Broeck J; Wit JM; Vossen JM
    J Pediatr; 1996 Oct; 129(4):544-50. PubMed ID: 8859261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth and growth hormone status following treatment for childhood leukaemia.
    Shalet SM; Brennan BM
    Horm Res; 1998; 50(1):1-10. PubMed ID: 9691206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation.
    Thomas BC; Stanhope R; Plowman PN; Leiper AD
    Eur J Pediatr; 1993 Nov; 152(11):888-92. PubMed ID: 8276017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
    Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
    Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
    Petersen FB; Deeg HJ; Buckner CD; Appelbaum FR; Storb R; Clift RA; Sanders JE; Bensinger WI; Witherspoon RP; Sullivan KM
    Int J Radiat Oncol Biol Phys; 1992; 23(5):1027-32. PubMed ID: 1639636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Petersen FB; Buckner CD; Appelbaum FR; Sanders JE; Bensinger WI; Storb R; Deeg HJ; Witherspoon RP; Sullivan KM; Clift RA
    Bone Marrow Transplant; 1992 Jul; 10(1):83-8. PubMed ID: 1515884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term complications of total body irradiation in adults.
    Thomas O; Mahé M; Campion L; Bourdin S; Milpied N; Brunet G; Lisbona A; Le Mevel A; Moreau P; Harousseau J; Cuillière J
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):125-31. PubMed ID: 11163505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation.
    Papadimitriou A; Urena M; Hamill G; Stanhope R; Leiper AD
    Arch Dis Child; 1991 Jun; 66(6):689-92. PubMed ID: 2053788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
    Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
    Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation.
    Deeg HJ; Flournoy N; Sullivan KM; Sheehan K; Buckner CD; Sanders JE; Storb R; Witherspoon RP; Thomas ED
    Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):957-64. PubMed ID: 6378850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team.
    Sanders JE
    Semin Hematol; 1991 Jul; 28(3):244-9. PubMed ID: 1716003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
    Cohen A; Rovelli A; Bakker B; Uderzo C; van Lint MT; Esperou H; Gaiero A; Leiper AD; Dopfer R; Cahn JY; Merlo F; Kolb HJ; Socié G
    Blood; 1999 Jun; 93(12):4109-15. PubMed ID: 10361107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid dysfunction among long-term survivors of bone marrow transplantation.
    Sklar CA; Kim TH; Ramsay NK
    Am J Med; 1982 Nov; 73(5):688-94. PubMed ID: 6753576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.